n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Friday, August 18th, 2017

The QualityStocks
Daily Stock List

graphic
graphic

Wealth Minerals Ltd. (WMLLF)

TradingView, MarketWatch, and InvestorsHub reported on Wealth Minerals Ltd. (WMLLF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Wealth Minerals Ltd. is a mineral resource company listed on the OTCQB. It has interests in Canada, Mexico, Peru and Chile. The Company’s chief focus is the acquisition of Lithium projects in South America. This includes interests in the Maricunga Salar in Chile. So far, Wealth Minerals has positioned itself to develop the Aguas Calientes Norte, Pujsa and Quisquiro Salars in Chile (the Trinity Project), and to work alongside existing producers in the prolific Atacama Salar. Wealth Minerals is based in Vancouver, British Columbia.

Additionally, Wealth Minerals maintains a portfolio of precious and base metal exploration-stage projects. This portfolio includes the 100 percent Wealth Minerals-owned Coronado property in southern Chihuahua, Mexico that spans 9911 Ha. The portfolio also includes Yanamina (Peru) and Valsequillo (Mexico).

Wealth Minerals announced in November 2016 that its wholly-owned Chilean subsidiary (Wealth Chile) entered into a formal option agreement with Atacama Lithium SpA, where it has been given the exclusive right and option to acquire a 100 percent royalty-free interest in 144 exploration concessions referred to as the Proyecto Atacama Lithium project situated in the Atacama Salar in Region II of Antofagasta, northern Chile.

The Company’s Wealth Chile entered into a Letter of Intent (LOI) dated December 12, 2016 with arm’s length vendors. Therefore, it was given the exclusive right and option to acquire a 100 percent royalty-free interest in the mining concessions referred to as the Laguna Verde project. The Project comprises 23 Concessions for a total of 2,438 hectares. It is in Region III (Atacama), northern Chile.

Recently, Wealth Minerals reported that it received positive results from the completed transient electromagnetic and gravity geophysical surveys at the Laguna Verde project.
The Company also announced that it signed a Letter of Intent (LOI) with Atacama Lithium Chile SpA regarding the grant of an option to acquire additional exploration mining concessions with an aggregate area of around 6,300 hectares surrounding the Laguna Verde Project and consisting of the Salar Green and Union projects that, if exercised, would bring its total land position in and surrounding Laguna Verde to about 8,700 hectares.

This month, Wealth Minerals announced that it executed a binding letter agreement, where it or a Chilean subsidiary of Wealth was granted the option and right to acquire 49 percent of the issued and outstanding shares of San Antonio Sociedad Contractual Minera and a 24.5 percent beneficial interest in certain exploration and exploitation mining concessions, which comprise the Salares 7 Lithium project (the Seven Salars Project). The Property is a lithium brine asset portfolio presently owned 50 percent by Talison Lithium Ltd. and 50 percent by San Antonio. It has a total area of 39,400 hectares located over seven salars in Region II, northern Chile.

Additionally, this month, Wealth Minerals announced that it closed the non-brokered private placement announced on June 2, 2017 and June 29, 2017. It issued a total of 3,704,946 common shares, including shares issued pursuant to finder’s fees, at a price of $1.50 per share for gross proceeds of $5,483,459.

The intention of the net proceeds from the Placement are to fund option payments on its mineral property options, the costs for the review and assessment of additional potential lithium mineral property acquisitions in South America, exploration work on its existing projects, and for general and administrative expenses and working capital purposes.

Wealth Minerals Ltd. (WMLLF), closed Friday's trading session at $1.4534, up 5.69%, on 150,111 volume with 162 trades. The average volume for the last 60 days is 51,632 and the stock's 52-week low/high is $0.593/$1.69.

Calmare Therapeutics, Inc. (CTTC)

OTCBB Journal, TaglichBrothers, and SmallCapVoice reported earlier on Calmare Therapeutics, Inc. (CTTC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Calmare Therapeutics, Inc. (the Calmare Pain Mitigation Therapy™ company) researches, develops, and commercializes chronic, neuropathic pain, and wound affliction devices. Calmare devices sell commercially to medical practices internationally. In addition, they are found in U.S. military hospitals, clinics, and on installations through the Company’s General Services Administration (GSA) military contract (V797P-4300B). Calmare Therapeutics is headquartered in Fairfield, Connecticut.

Calmare’s medical devices provide a non-pharmacological (no drugs), non-addictive (no narcotics), and non-invasive (over the skin) solution to chronic pain sufferers in an outpatient treatment setting. The Company supplements its medical devices with a catalogue of private label neurostimulation and sensory electrodes.

The Company’s flagship medical device is the Calmare® Pain Therapy Device. This is the world's only non-invasive and non-addictive modality that can successfully treat chronic, neuropathic pain. Calmare Therapeutics holds a U.S. Food & Drug Administration (FDA) 510k clearance designation (K081255) on its flagship device. This grants it the exclusive right to sell, market, research, and develop the medical device in the United States.  

Concerning CALMARE® Pain Therapy Treatment, the device is FDA-cleared for U.S. sales, U.S. patented, and patent pending in other countries, and medically certified in Europe. The Calmare® Pain Therapy Device treats oncologic and neuropathic pain through a biophysical rather than biochemical approach.

In January 2017, Calmare Therapeutics announced it was approved to list and supply four sensory and stimulation electrodes and the Calmare® Pain Therapy Device on the GSA Advantage!® web portal. GSA Advantage! is the online shopping and ordering system, which provides access to thousands of contractors and millions of supplies (products) and services.

Calmare Therapeutics has been a preferred vendor of the U.S. federal government (GSA#V797P-4300b) since 2010. Devices, consumables, as well as related hardware sell to U.S. military hospitals and clinics across the U.S. The Company sells its devices in Europe under CE-mark designation.

Calmare creates partnerships with its clients and customers to maximize their Intellectual Property (IP) assets, reduce time-to-market, and add to their profitability. The Company’s Technology Sourcing Service seeks technologies that fit with customer business goals and presents them as potential licensing or IP acquisition candidates.

Greater than 6,000 chronic pain patients have been successfully treated with Calmare Pain Mitigation Therapy™ since the initial Calmare chronic pain treatment was administered in 2007. Calmare Therapeutics has licensed more than 500 technologies to more than 400 individual organizations.

Calmare Therapeutics, Inc. (CTTC), closed Friday's trading session at $0.12, up 8.11%, on 12,000 volume with 4 trades. The average volume for the last 60 days is 12,345 and the stock's 52-week low/high is $0.071/$0.235.

Magellan Gold Corp. (MAGE)

Penny Stock Pick Alert, RisingPennyStocks, SixFigureStockPicks, Greenbackers, PennyPickAlerts, PennyStockMoneyTrain, Pumps and Dumps, FOX Penny Stocks, Joe Penny Stocks, Liquid Tycoon, Penny Stock Pick Report, Super Hot Penny Stocks, Super Nova Stock Picks, WePickPennyStocks, and Winning Penny Stock Picks reported on Magellan Gold Corp. (MAGE), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Magellan Gold Corp.’s primary business is the acquisition and exploration of mineral resources. The OTCQB-listed Company engages in the acquisition and exploration of precious metals mineral properties. Its updated strategic goal is building a mid-tier precious metals exploration and mining company.  Magellan Gold is headquartered in Vacaville, California.

Magellan has its "Silver District" project. This project consists of 94 unpatented lode mining claims, 6 patented lode claims, an Arizona mining lease of 335 acres, and 23 unpatented mill site claims, totaling greater than 2,000 acres. Magellan Gold holds its properties via its 85 percent owned subsidiary Gulf & Western Industries, Inc.

Its district-scale property position encompasses the core of the historic Silver District in La Paz County, about 50 miles north of Yuma. At the Silver District Project in southwest Arizona, the Company’s goal is to expand its resource base containing an historic resource of 16 million ounces of silver. It also plans to acquire additional advanced-stage properties that have tangible promise for development.   

Magellan Gold has the right to earn an undivided 50 percent interest in the Niñobamba Silver/Gold Project in central Peru. To earn its 50 percent interest, the Company must spend $2.0 million in exploration over three years. The Niñobamba project covers 9,027 acres and demonstrates potential for a large, bulk tonnage, silver-gold deposit.

Rio Silver and its project partner, Magellan Gold, announced this past February that they initiated exploration work on the expanded Niñobamba Project. Recent strategic additions to the land package have created a large, contiguous property comprising 3100 hectares and another 553-hectare concession pending title confirmation. Magellan Gold will be spending US$2 million at the Niñobamba project to earn its 50 percent interest.

This past March, Magellan Gold announced that it entered into a Memorandum of Understanding (MOU) with Rose Petroleum plc to purchase an operating floatation plant, which also includes a precious metals leach circuit and associated assets, licenses and agreements (together, the SDA Mill), located in the State of Nayarit, Mexico, for a total consideration of US$1.5 million. The basis of the mill's normal operation is on sales of floatation concentrates to smelters, and payment for precious metals content. The mill currently engages in toll milling for third party ore producers. Rose Petroleum is a multi-asset natural resource enterprise.

This week, Magellan Gold announced it arranged $900,000 in irrevocable bridge loans in support of its option to purchase the SDA Mill from Rose Petroleum. The bridge loans are enough to complete the cash component of the purchase price and have the effect of extending the purchase option until closing of the transaction.

To extend the option, Magellan Gold had the obligation to secure the bridge loans on or before August 15, 2017. Total consideration for the purchase is US $1.5 million, comprising $1.0 million in cash and $500,000 in Magellan stock, of which $100,000 in cash already was paid.

Magellan Gold Corp. (MAGE), closed Friday's trading session at $0.0812, down 14.07%, on 24,997 volume with 5 trades. The average volume for the last 60 days is 206,965 and the stock's 52-week low/high is $0.065/$0.28.

Rego Payment Architectures, Inc. (RPMT)

InvestorsHub, Investing, and MarketWatch reported on Rego Payment Architectures, Inc. (RPMT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Rego Payment Architectures, Inc. previously operated under the name Virtual Piggy, Inc. On March 16, 2017, the Company, creators of the only COPPA compliant technology targeted at providing payment capability for the under 18 market, announced its name change to reflect the progression of the Company into broader payment-related markets.

REGO Payment Architectures, Inc. became an umbrella under which the Intellectual Property (IP) developed becomes available to many varied industries beyond the under 18 market. OTCQB-listed, Rego Payment Architectures is based in Palm Beach, Florida.

The Company’s core technology base is established on validated artificial intelligence (AI) techniques. It has wide-ranging capability to adapt to a broad array of payment markets and users. The core technology consists of ReTRO (Real Time Regulatory Oversight), established on advanced AI techniques, a system of reasoning engines, and a Contract Model (CM) that permits the creation of specific boundary conditions for its use.

Additionally, the Company has its NOMad (Networks of Meaning ad-vantage). This is an advanced data mining application, which monitors people and the things they interact with. Also, Rego has its RSM (REGO Payment Architectures, Secure Financial Messaging) - the payment control system.

REGO Payment Architectures signed a definitive agreement with Be Informed BV, effective July 2017, for the Company’s commercial launch of its inventive digital mobile payment system. The terms and conditions allow Rego's COPPA compliant OINK payment platform unlimited use of its developed technology to be available to children and their families for direct mobile payments.

Rego Payment Architectures and Be Informed have also entered into three new MOU’s in expectation of the many and various expanding markets where this mobile payment technology will be advantageous. The MOU's allow Rego to enter into production agreements under similar terms and conditions to its OINK payment platform. The agreements cover the expected welfare benefits, the unbanked, and closed loop platforms.

REGO Payment Architectures recently announced that it demonstrated the Beta version of the OINK Payment System for Children. OINK (Online Instant Networking Keypad) is a technology that speeds up payments and makes making payments simple and streamlined. This Beta release is a significant milestone for the Company. It sets the stage for the general release in September 2017 when it will be tested by 400 students of diverse demographic backgrounds in four independent schools. Rego is presently in the process of security testing to ensure that the system has all the protection it needs for transaction processing and data integrity.

Last month, Rego Payment Architectures announced the appointment of Mr. David Knight as its Chief Operating Officer (COO) and President. Mr. Knight is an experienced industry executive. He has almost thirty years of experience working for Fortune 500 companies. These include eBay, PayPal, Quaker Oats, PepsiCo, Gatorade, and Frito Lay.

Rego Payment Architectures, Inc. (RPMT), closed Friday's trading session at $0.31, up 46.64%, on 48,813 volume with 16 trades. The average volume for the last 60 days is 13,650 and the stock's 52-week low/high is $0.10/$0.5313.

Evans Brewing Company, Inc. (ALES)

MarketWatch reported on Evans Brewing Company, Inc. (ALES), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Evans Brewing Company, Inc. is a producer of award-winning craft beers and the owner of The Public House restaurant and tap room. The Company brews and distributes premium craft brands that have been honored with over 20 international awards. Evans Brewing supplies restaurants, retailers, and beer drinkers across seven western states. The Company has its brewery in Irvine, California.

Evans Brewing Company operates the oldest brewery in Orange County, California. Additionally, it offers its ales and lagers, along with a complete Gastropub food menu at its restaurant and tap room, The Public House by Evans Brewing Company.

The Public House is in the Soco District of downtown Fullerton, California. The eatery features an innovative pub food menu, made in its scratch kitchen. This complements the Company’s craft beers. The space features dark-wood floors, exposed brick, as well as artwork. This highlights the brand’s Orange County and California roots. The Public House offers live music. This includes jazz and a broad selection of different genres.

Evans Brewing Company has produced the initial beer in its small batch brewing system - two variations of its Original Pilsner. The expectation is that these will be available at The Public House. The variations of The Original include one using German dry hops and another using American dry hops.

Evans Brewing announced in December 2016 that it signed a ten-year lease for its second Public House location next to The Triangle in Costa Mesa, California. The Triangle is one of Orange County's premier dining and entertainment destinations.

The second Public House by Evans Brewing Company is at 110 Broadway, Costa Mesa. This is close to a number of popular bars and restaurants along Newport Boulevard near the Costa Mesa and Newport Beach border.

In January 2017, Evans Brewing Company announced that it signed a ten-year lease for another Public House location at the Bella Terra Mall in Huntington Beach, California. The Bella Terra Mall is one of the premier dining and entertainment destinations in the area. DJM Capital Partners, Inc. manages this Mall.

Evans Brewing has released "Stout at the Devil," a Russian Imperial Stout. The product is in kegs but will join Pollen Nation, KrHOPen IPA, Chocolatte Chocolate Porter and Oaklore Brown Ale as a year-round offering.

Evans Brewing has hired Mr. Micah Schiesel, former Director of Restaurant Operations at Golden Road Brewery in Los Angeles, California. Mr. Schiesel was with Golden Road from February 2013 until March 2017. Before that he was GM at Simmzy's in Belmont Shore, Chronic Cantina in Costa Mesa and Upland, and Manager at Mastro's Ocean Club.

Furthermore, the Company has hired Mr. Peter Pallad, a former high-end craft manager for an AB InBev owned distributor, to head up brewery sales. Mr. Pallad is an industry veteran with more than 8 years in the craft beer industry selling craft beer in New York, New York.

Evans Brewing Company, Inc. (ALES), closed Friday's trading session at $1.05, even for the day. The average volume for the last 60 days is 2,334 and the stock's 52-week low/high is $0.56/$4.25.

graphic

The QualityStocks
Company Corner

graphic
graphic

InMed Pharmaceuticals, Inc. (CSE:IN) (OTCQB:IMLFF)

The QualityStocks Daily Newsletter would like to spotlight InMed Pharmaceuticals, Inc. (IMLFF). Today, InMed Pharmaceuticals, Inc. closed trading at $0.25, up 1.09%, on 154,874 volume with 83 trades. The stock’s average daily volume over the past 60 days is 353,862, and its 52-week low/high is $0.059/$0.72.

InMed Pharmaceuticals, Inc. ("InMed" or the "Company") (CSE: IN; OTCQB: IMLFF), a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based drug therapies, is pleased to announce that it has entered into a consulting agreement with Creative Capital Media ("CCM"), a media and advertising consultancy, to provide communication and awareness services to InMed in North America.

InMed Pharmaceuticals, Inc. (IMLFF) is a preclinical-stage biopharmaceutical company specializing in the development of novel therapeutics leveraging the pharmacological benefits of cannabinoids. Utilizing its proprietary bioinformatics assessment tool, InMed aims to identify bioactive compounds found within the cannabis plant that have the potential to offer optimized therapeutic benefit while demonstrating limited adverse effects. This assessment tool, in combination with the company’s cannabinoid biosynthesis technology and drug development pipeline, serves as InMed’s fundamental value driver.

Bioinformatics is a proprietary, computer-based program designed to assist in the identification of novel cannabinoids using comprehensive algorithms to integrate data from numerous bioinformatics databases, as well as a database on the structure of currently approved pharmaceutical products and an extensive database on over 90 individual cannabinoid drugs found in cannabis. This extensive collection of data is derived from both public and propriety-based sources. Leveraging this tool, the company aims to create associations between approved pharmaceuticals and cannabinoids with similar structures in order to identify active cannabinoids that have the potential to treat specific diseases. Per InMed’s website, this type of bioinformatics assessment represents “significant promise for future drug discovery, as it integrates many data sets and builds holistic models to approach a specific disease.”

After discovering these promising active cannabinoids, InMed moves to test and confirm their activity in biological systems through in vitro and in vivo experimentation. It is at this stage of development that the company’s proprietary biosynthesis process of cannabinoid manufacturing will be most promising. InMed is currently developing a robust, high-yield biosynthesis process for manufacturing all 90+ naturally-occurring cannabinoids. By modifying the agriculture-based formula for harvesting cannabinoids, InMed aims to combine the inherent safety and known efficacy of the natural drug structure with the convenience, control and quality of 21st Century laboratory-based manufacturing processes.

The company’s pipeline currently includes two drug candidates in preclinical development, including INM-750 for the treatment of epidermolysis bullosa (EB) and INM-085 for the treatment of glaucoma. Referred to by the Dystrophic Epidermolysis Bullosa Research Association of America as “The Worst Disease You’ve Never Heard Of,” EB is a rare genetic connective tissue disorder that affects roughly one out of every 20,000 births in the United States. The condition currently has no approved treatment or cure. Through the development of INM-750, InMed is attempting to address this significant unmet medical need. The drug candidate replaces missing keratins in the skin with specially selected cannabinoids in an effort to modulate the painful manifestations of EB.

INM-085, InMed’s second development candidate, is formulated to reduce the elevated intra-ocular pressure that is often associated with glaucoma. Additionally, the cannabinoids utilized in INM-085 are expected to provide neuroprotection for the retinal ganglion cells and other optic nerve tissues following topical administration. Although it is still in preclinical development, INM-085 targets a sizable market. According to the Glaucoma Research Foundation, glaucoma is a leading cause of blindness with no approved cure. The National Institutes of Health estimates that more than 3 million Americans currently have glaucoma, and more than 120,000 have been blinded by the disease.

InMed is focused on progressing toward validation of its drug candidate selection, using data to secure its patents and developing key disruptive technologies. In 2016, the company was successful in completing financings of $1.9 million. In January 2017, InMed completed a non-brokered private placement of common shares generating aggregate gross proceeds of C$1.5 million, strongly positioning the company to attract the new investment required to fund its aggressive growth strategies in 2017.

The company’s management team has well over a century of combined experience in the biopharmaceutical space. Company CEO Eric Adams has more than 25 years of experience in company and capital formation, global market development, mergers and acquisitions, licensing and corporate governance. During his time as CEO of enGene Inc., he led the gene therapy startup to a position at the head of the industry.

Joining Adams on the InMed management team are Chief Scientific Officer Dr. Sazzan Hossain; Senior Vice President, Clinical and Regulatory Affairs Alexandra D.J. Mancini; SVP, Corporate Strategy & Investor Relations Chris Bogart; and Chief Financial Officer Jeff Charpentier, as well as Chief Medical Officer Dr. Ado Muhammed, MD, DPM, MFPM.

Muhammed, in particular, has an extensive history in the pharmaceutical industry, having previously served as an executive of GW Pharmaceuticals, a global leader in the development of cannabinoid-based medicines. During his time as Associate Medical Director of that company, Muhammed played an instrumental role in the development and FDA approval of one of the first cannabis drugs. This GW Pharmaceuticals development program coincided with a sharp rise in share price from less than $9 in 2013 to more than $129 today, with the company’s current market value totaling more than $2.9 billion. Disclaimer

InMed Pharmaceuticals, Inc. Company Blog

InMed Pharmaceuticals, Inc. News:

InMed Announces Appointment of Creative Capital Media

InMed Announces Publication in European Journal of Pain

InMed Pharma Advances Cannabinoid EB Therapy -- CFN Media

HighCom Global Security, Inc. (HCGS)

The QualityStocks Daily Newsletter would like to spotlight HighCom Global Security, Inc. (HCGS). Today, HighCom Global Security, Inc. closed trading at $0.017, up 18.88%, on 3,500 volume with 2 trades. The stock’s average daily volume over the past 60 days is 5,958 and its 52-week low/high is $0.0051/$0.10.

HighCom Global Security, Inc. (HCGS) is a manufacturer and distributor of protective products for military and law enforcement personnel. The Corporation operates under two segments, BlastGard Defense Group and Highcom Security.

BlastGard is a blast mitigation specialist with proprietary material proven to effectively mitigate blasts and suppress fires resulting from explosions. The company's patented BlastWrap® technology acts as a "virtual tent" to effectively mitigate blast effects and suppress post-blast fires. This unique technology works by triggering physical and chemical processes to dissipate blast energy, thereby reducing the aftermath of acoustic and shock waves, peak overpressure, reflected peak overpressure, impulse and afterburn. The remaining, significantly reduced energy is transmitted at a slower, more sustainable level. Notably, BlastWrap does not dispense chemical extinguishants; uses neither alarms, sensors, nor an activation system; and is nontoxic and ecologically friendly.

Similarly, the company's BlastGard MTR trash receptacles dramatically reduce lethal threats posed by the detonation of an improvised explosive device (IED). Equipped with Triple Wall Technology, BlastGard MTR mitigates primary fragments, secondary fragments, mechanical effects (shock/blast pressure) and thermal effects (contact and radiation burn) from the fireball, after-burn and resultant post-blast fires.

BlastGard's primary market focus lies on providing blast effects mitigation solutions for customers operating in the commercial sector, military, law enforcement and government agencies. With a vision of being recognized as the leading provider of environmentally responsible solutions to protect lives and structures from the hazards associated with fire and explosions, the company is capable of addressing a wide array of industry applications spanning from fire suppression for naval vessels and merchant ships to protection of buildings against vehicle bombs.

This vision is supported by the ban of Halon extinguishing agents, as outlined in the Montreal protocol, which effectively establishes BlastWrap® as the only blast and fire suppression means available for most applications, including adaptation for underwater use.

The company's position at the head of the blast suppression market has helped BlastGard attain a number of government awards, including designation of its BlastWrap® product as a Qualified Anti-Terrorism Technology and placement on the "Approved Products List for Homeland Security." This designation was extended in early 2017, meaning that BlastWrap® is approved for use by the Department of Homeland Security under the SAFETY Act until November 2021.

HighCom Security, develops, tests, manufactures and distributes body armor and personal protective equipment, including more than two dozen NIJ (National Institute of Justice) compliant hard and soft armor products. Highcom Security has a 20-year history of producing quality armor with no operational failures and no recalls of its American made products.

Highcom Security was founded in 1997 and has produced close to 1 million pieces of armor for the Global community. The company is ISO 9001:2008 certified and the first company in the world to be BA 9000:2012 certified compliant.

For the past decade, Highcom Security has also been able to offer some of the largest armor manufacturers with private label/OEM hard armor solutions for end use by military and law enforcement agencies globally, a market reach obtained because of the company's reputation for innovative technology, exceptional customer service and superior quality performance. Disclaimer

HighCom Global Security, Inc. Blog

HighCom Global Security, Inc. News:

HighCom Global Security Introduces New CEO and Board of Directors as Part of Globally Focused Restructuring Plan

BlastGard International, Inc. Announces Name and Symbol Change to HighCom Global Security, Inc. (HCGS), Rebranding Initiative to Reflect Expanded Growth Strategy

BlastGard International, Inc. (BLGA) Engages NetworkNewsWire for Corporate Communications Solutions

Singlepoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight Singlepoint, Inc. (SING). Today, Singlepoint, Inc. closed trading at $0.071, up 14.89%, on 25,809,967 volume with 1,508 trades. The stock’s average daily volume over the past 60 days is 19,153,548, and its 52-week low/high is $0.0075/$0.415.

Singlepoint, Inc. (SING) has grown from a full-service mobile technology provider to a publicly-traded holding company. Through diversification into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued subsidiaries, thereby providing a rich, diversified holding base.

SinglePoint's approach is to first research and identify acquisition opportunities in which it can take an active and influential role among existing leadership to provide enhanced strategy and direction. Target companies are undervalued, cash-flow positive, with high potential and verified assets. SinglePoint acquires and takes controlling interest of successful candidate companies.

SinglePoint recently signed a Letter of Intent to acquire an interest in Jacksam Corp., dba Convectium, a profitable California-based provider of equipment, branding, and packaging solutions for the cannabis industry. Convectium has developed the world's first cartridge and vape pen oil filling machine for wholesale distribution to dispensaries. The 710Shark and 710Seal systems can fill and package over 100 cartridges or disposable vape pens in 30 seconds and are sold to dispensaries through its EquipCanna.com brand. The company also operates a consumer brand that includes BlackoutX and HazeSticks and reaches customers in over 52 countries.

Additionally, SinglePoint has raised more than $300,000 and has signed a Letter of Intent to secure an additional $1 million in funding. The move provides management with ample capital to execute its business plan, while avoiding debt repayments that can eat into cash flow and reduce flexibility over time. It's also a rare development for a development-stage company in the cannabis industry.

Guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital, SinglePoint continues to explore high-potential acquisition opportunities to grow and diversify its current holding base. The company also plans to uplist to the OTCQB and become a fully reporting company during the current fiscal year.

The company has engaged Milost Advisors to pursue acquisitions and financing facilities toward funding acquisitions, as well as to provide working capital. Milost Advisors will assist SinglePoint in the acquisition of undervalued companies with annual revenues of at least $50 million, and has already identified potential acquisition targets for the company to consider. Disclaimer

Singlepoint, Inc. Company Blog

Singlepoint, Inc. News:

NetworkNewsWire Announces Publication Highlighting Investment Prospects Employing Cryptocurrency in the Legal Marijuana Industry

SinglePoint Invests in WeedCoin Cryptocurrency -- CFN Media

NetworkNewsWire Announces Publication Discussing Bitcoin's Potential to Fill the Void of Federal Banking Resources in the Legal Marijuana Industry

Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE). Today, Global Payout, Inc. closed trading at $0.021, off by 8.70%, on 4,046,667 volume with 135 trades. The stock’s average daily volume over the past 60 days is 337,947, and its 52-week low/high is $0.0077/$0.04.

Global Payout, Inc. (GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout's fully configurable "banking-in-a-box" web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today's banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout's management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and "high-risk" market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and "high-risk" enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions. Disclaimer

Global Payout, Inc. Company Blog

Global Payout, Inc. News:

Global Payout, Inc. Finalizes Licensing Agreement with Cagney Global Logistics for the use of the Global Payout Technology Platform

Global Payout, Inc. and MoneyTrac Technology Enter the Multi-Billion Dollar CBD Market through their Agreement with H Smart, Inc.

Marijuana Company of America Completes $250,000 Investment in MoneyTrac Technology

AppSwarm, Inc. (SWRM)

The QualityStocks Daily Newsletter would like to spotlight AppSwarm, Inc. (SWRM). Today, AppSwarm, Inc. closed trading at $0.89, even for the day, on 37,765 volume with 51 trades. The stock’s average daily volume over the past 60 days is 48,794 and its 52-week low/high is $0.12/$2.75.

AppSwarm, Inc. (SWRM) is a technology development and incubation acceleration company that partners up with developers through joint ventures, royalty agreements, marketing partnerships, and outright purchase agreements. Focusing on the ever-growing mobile applications market, the company provides all the resources needed for engagement, retention, virality and monetization.

The global games market generated approximately $100 billion in revenues in 2016, but large global game companies have made it extremely difficult for smaller developers to achieve success in the marketplace. As a result, many great ideas aren't monetized. AppSwarm solves this problem by providing the funding and critical business expertise needed to successfully launch and market new applications.

Business applications is another area of focus for the company. Targeting small to medium sized businesses, AppSwarm will be developing and acquiring mobile application tools and platforms that increase productivity and security via data encryption, cloud storage, content management and delivery, digital payments, automation, and customer loyalty marketing solutions. Recent acquisitions made so far represent only a small example of future planned initiatives to develop and market tools for the business community.

Regardless of the target market, AppSwarm can help developers accelerate the success of their app through funding, technology and marketing expertise, as well as a unique eco system that accelerates user acquisition. The company is able to assist at any state of development with completion of concept, market analysis, business and financial management, direct sales and marketing, social game development to ensure correct product application and expedient deployment with cost efficiency.

Ron Brewer, CEO of the company, has accumulated extensive leadership in the technology sector and brings valuable knowledge gained as a Director of Southbridge Advisory Group for nearly 20 years. Ron's C-level experience includes merger & acquisition and post-acquisition turnaround in both the private and small-cap public sector. John Rabbit, director of finance, is a seasoned business veteran that has worked with Fortune 500 firms and served in CEO, COO and CFO positions for firms ranking from $5 million to $300 million in annual revenues. John was directly involved in numerous acquisitions and served in executive capacities for several multinational subsidiaries.

With a well-suited management team, multiple synergistic revenue streams, and diversified growth strategy, AppSwarm is well positioned in a steadily growing industry with countless opportunities for capitalization. Disclaimer

AppSwarm, Inc. Blog

AppSwarm, Inc. News:

AppSwarm Announces Acquisition of Multiplatform Games Developer and Publisher MediaPlay and the Creation of Two Divisions of AppSwarm, Inc.

AppSwarm, Inc. (SWRM) Ahead of the Game as It Seeks to Increase Choice for More than 2 Billion Players

AppSwarm to Expand into Mobile Business Applications

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

PennyPickAlerts
(WMHI) +128.18%

2.

OTCtipReporter
(DDXSQ) +100.00%

3.

QualityStocks
(RPMT) +46.64%

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251